accepted and acknowledged
on 04 Sep 2020
Last Applicant/ Owned by
2200 Pennsylvania Ave. NW
Washington
DC
20037
Serial Number
86185566 filed on 05th Feb 2014
Registration Number
4756956 registered on 16th Jun 2015
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"TASIMELTEON CAPSULES"
The mark consists of "Hetlioz" on a first line, and "(tasimelteon) capsules" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text. Pharmaceutical preparations, containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous systRead More
Pharmaceutical preparations, containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation
15th Apr 2014
15th Apr 2014
No 86185566
No Service/Collective Mark
No VAND-0129-US
No
No
No
No
No
No
No
No
26.17.03 -
Dotted line(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of "Hetlioz" on a first line, and "(tasimelteon) capsules" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.
| Status Date | Action Taken |
|---|---|
| 04th Sep 2020 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 04th Sep 2020 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 02th Sep 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 16th Jun 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 16th Jun 2020 | TEAS SECTION 8 & 15 RECEIVED |
| 16th Jun 2015 | REGISTERED-PRINCIPAL REGISTER |
| 13th May 2015 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 12th May 2015 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 22nd Apr 2015 | STATEMENT OF USE PROCESSING COMPLETE |
| 22nd Apr 2015 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
